Immunologic strategies for HIV-1 remission and eradication.
about
Combination of nanoparticle-based therapeutic vaccination and transient ablation of regulatory T cells enhances anti-viral immunity during chronic retroviral infectionDynamic models of viral replication and latencyInduction of intestinal immunity by mucosal vaccines as a means of controlling HIV infectionAntiviral Therapy by HIV-1 Broadly Neutralizing and Inhibitory AntibodiesNew concepts in HIV-1 vaccine developmentMight dolutegravir be part of a functional cure for HIV?Broadly Neutralizing Antibodies for HIV EradicationOngoing Clinical Trials of Human Immunodeficiency Virus Latency-Reversing and Immunomodulatory AgentsBioinformatics and HIV latency.A network intervention that locates and intervenes with recently HIV-infected persons: The Transmission Reduction Intervention Project (TRIP)Levels of HIV-1 persistence on antiretroviral therapy are not associated with markers of inflammation or activation.Advancements in Developing Strategies for Sterilizing and Functional HIV Cures.Simian immunodeficiency virus infection and immune responses in the pig-tailed macaque testis.Biomarker reveals HIV's hidden reservoir.The transient HIV remission in the Mississippi baby: why is this good news?Progress towards an HIV cure: update from the 2014 International AIDS Society SymposiumImmuno-modulatory strategies for reduction of HIV reservoir cells.Toward a biorelevant structure of protein kinase C bound modulators: design, synthesis, and evaluation of labeled bryostatin analogues for analysis with rotational echo double resonance NMR spectroscopyBroadly neutralizing antibody and the HIV reservoir in acute HIV infection: a strategy toward HIV remission?HIV eradication symposium: will the brain be left behind?CD4:CD8 ratio as a frontier marker for clinical outcome, immune dysfunction and viral reservoir size in virologically suppressed HIV-positive patients.Optimal Combinations of Broadly Neutralizing Antibodies for Prevention and Treatment of HIV-1 Clade C Infection.Specific Elimination of Latently HIV-1 Infected Cells Using HIV-1 Protease-Sensitive Toxin Nanocapsules.The Effect of Therapeutic HIV Vaccination With ALVAC-HIV With or Without Remune on the Size of the Viral Reservoir (A CTN 173 Substudy).Enigma of HIV-1 latent infection in astrocytes: an in-vitro study using protein kinase C agonist as a latency reversing agent.Potent and Broad Inhibition of HIV-1 by a Peptide from the gp41 Heptad Repeat-2 Domain Conjugated to the CXCR4 Amino TerminusCell-Associated HIV-1 DNA and RNA Decay Dynamics During Early Combination Antiretroviral Therapy in HIV-1-Infected Infants.Novel Assays for Measurement of Total Cell-Associated HIV-1 DNA and RNA.Antibody Responses After Analytic Treatment Interruption in Human Immunodeficiency Virus-1-Infected Individuals on Early Initiated Antiretroviral Therapy3-Hydroxypyrimidine-2,4-dione-5-N-benzylcarboxamides Potently Inhibit HIV-1 Integrase and RNase H.HIV cure research: a formidable challengeDevelopment of an Attenuated Tat Protein as a Highly-effective Agent to Specifically Activate HIV-1 LatencyAd26/MVA therapeutic vaccination with TLR7 stimulation in SIV-infected rhesus monkeys.In vitro effects of the small-molecule protein kinase C agonists on HIV latency reactivation.Blocking type I interferon signaling enhances T cell recovery and reduces HIV-1 reservoirs.Design and In Vivo Characterization of Immunoconjugates Targeting HIV gp160.Identification of Human Anti-HIV gp160 Monoclonal Antibodies That Make Effective Immunotoxins.Association of Arterial and Lymph Node Inflammation With Distinct Inflammatory Pathways in Human Immunodeficiency Virus Infection.International AIDS Society global scientific strategy: towards an HIV cure 2016.Targeting HIV latency: resting memory T cells, hematopoietic progenitor cells and future directions.
P2860
Q26748624-43C349AD-9F2C-4F52-A632-8442629311B8Q26866136-1FE76400-CC4A-41A5-85FB-8A344EE44208Q27001897-AD991E72-6430-4CEC-AD69-89FE5133BC1EQ28066335-9ADF03CD-2A0A-4952-9927-C638ABC7F673Q28067027-1133FC48-3A81-4D2C-A0F2-B7E20B9DC89CQ28071420-F464D004-2468-4BCC-B131-F38A0990C030Q28073939-4FF75B0F-CFD4-4288-9E43-494EAA7E606AQ28079455-1E9D36A7-21A8-434F-9AA4-D580FD4FEECAQ28081427-3A4F37AE-77CF-4BBB-B375-D5773057565BQ29248885-BD69332D-D7E3-4931-8B74-60328FF7904BQ33585386-151BAA66-F11C-47EC-9632-BF4EBE3D7987Q33654409-A3B3B6A7-A28B-4613-AF1A-6F6D1AC7F599Q33816786-BDA367C6-6C2D-48F6-AF90-5015EDF7E272Q34350403-7078BC90-FCC3-4FF9-B5BA-AA7E987C17F4Q34558518-1CB96EF5-66E2-43F2-A0A9-8430DEF03C69Q34869380-996E2EC7-EF8D-43AF-A77F-1EE87EB900A5Q35329923-E4EB8791-8E84-41A8-AE3F-90CD682AEAA2Q35511561-DDD316C4-5AD1-4907-96E5-F006785815E7Q35595846-939290EC-D889-4902-A672-5E6BD5F208E6Q35607587-49A50F84-0E13-4590-AC81-BB3EF74B6443Q35801549-A92A5067-1412-4407-9963-2EFFDAD5DC81Q35974269-5E1B4139-7D21-4B5C-BB0F-B1A9869488A0Q35980789-47DDB50E-EDCF-466D-B4A7-7AF2B3BF6E1AQ36080407-61884DE7-9173-440A-B1B8-99B1362F38B5Q36131249-2646592C-CD06-415C-A9FF-0D27A0EC6066Q36195192-2F17CE93-E1CB-421E-8A63-10512E0190E8Q36311438-64B2A790-7A8C-4713-8F80-D587D51C7B02Q36734972-D0AAC39B-345F-42CC-9ED8-1F1D812A3081Q37091564-B9A83DD8-30A7-4B46-87B0-D6C759DA8463Q37095708-F2502863-8A87-4601-ABB0-5D547CC9527DQ37098202-2B3B8E9D-675F-4B36-AE00-05F3F5BD8C25Q37419972-B5DFFEC4-9706-4350-A7CB-C85E9FD9262AQ37486401-D27D1FF5-C234-4A51-BA2E-FF0BB7E2D169Q37493633-99525543-C271-4224-805A-725CF0A7506AQ37545050-ED7EBE01-0FEF-4FC0-8E01-4153985695B6Q37593171-50B5E00C-9AD2-4228-A654-AB8104BD03C6Q37593177-AE4B9B57-1C98-4782-9720-4E9BBD07FD12Q37643812-00DE9FAE-052E-4330-BB72-CA78E080F6FEQ37661770-7FFAA124-5473-4C1A-90A4-0D82B6C7FB0BQ38246141-A0FD6C45-EA0B-4DFF-B2BE-2E92DE3EB616
P2860
Immunologic strategies for HIV-1 remission and eradication.
description
2014 nî lūn-bûn
@nan
2014 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Immunologic strategies for HIV-1 remission and eradication.
@ast
Immunologic strategies for HIV-1 remission and eradication.
@en
type
label
Immunologic strategies for HIV-1 remission and eradication.
@ast
Immunologic strategies for HIV-1 remission and eradication.
@en
prefLabel
Immunologic strategies for HIV-1 remission and eradication.
@ast
Immunologic strategies for HIV-1 remission and eradication.
@en
P2860
P356
P1433
P1476
Immunologic strategies for HIV-1 remission and eradication.
@en
P2860
P304
P356
10.1126/SCIENCE.1255512
P407
P577
2014-07-01T00:00:00Z